Disrupted Serotonergic and Sympathoadrenal Systems in Patients with Chronic Heart Failure May Serve as New Therapeutic Targets and Novel Biomarkers to Assess Severity, Progression and Response to Treatment

Razina Nigmatullina,Venera V. Kirillova,Roen K. Jourjikiya,Marat A. Mukhamedyarov,V. S. Kudrin,P. M. Klodt,András Palotás

Disrupted Serotonergic and Sympathoadrenal Systems in Patients with Chronic Heart Failure May Serve as New Therapeutic Targets and Novel Biomarkers to Assess Severity, Progression and Response to Treatment

2009

Razina Nigmatullina
Venera V. Kirillova
Roen K. Jourjikiya
Marat A. Mukhamedyarov
V. S. Kudrin
P. M. Klodt
András Palotás

Background: It is well established that the serotonergic system (SS) plays important roles in the pathogenesis of cardiovascular diseases. However, the impact of serotonin and its i

Keywords:

Cardiology
Left ventricular hypertrophy
Pathogenesis
Dopamine
Serotonin
Internal medicine
Diabetes mellitus
Heart failure
Biomarker (medicine)
Serotonergic
Medicine

Correction
Source
Cite
Save
Machine Reading By IdeaReader

References

Citations